FFCP PHASE1:Mm9::chr9:45054257..45054261,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=142|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr9:45054257..45054261,-|id=chr9:45054257..45054261,-|ontology_enrichment_celltype=CL:0000553!2.17e-07!6;CL:0000556!2.17e-07!6|ontology_enrichment_celltype_v019_2=CL:0000355,9.19e-09,9|ontology_enrichment_disease=DOID:0060100!2.44e-07!3;DOID:4045!2.44e-07!3|ontology_enrichment_disease_v019_2=DOID:0060100,3.91e-24,3;DOID:4045,3.91e-24,3;DOID:0050686,1.24e-12,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,9.19e-09,9;UBERON:0002036,9.19e-09,9;UBERON:0002385,9.19e-09,9;UBERON:0000486,9.19e-09,9;UBERON:0007503,9.19e-09,9;UBERON:0001015,9.19e-09,9;UBERON:0002329,9.19e-09,9;UBERON:0003082,9.19e-09,9;UBERON:0003059,9.19e-09,9;UBERON:0007282,9.19e-09,9;UBERON:0004290,9.19e-09,9;UBERON:0009618,9.19e-09,9;UBERON:0000383,5.53e-08,10;UBERON:0007524,2.41e-07,11;UBERON:0003077,2.41e-07,11;UBERON:0007285,2.41e-07,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.473193248037357,0.685572168028694,0.42438965179803,0,0.0992909512008853,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.92972141515835,4.6880120671428,0,4.1176204162171,8.19654581950135,1.45653105909346,0,0,0,0,0,0,0,0,0,0.503347818173209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.153606533256243,0,0,0,0.279182999001381,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.702213187313235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307435147943927,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202725215290164,0,0,0.179026695667481,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr9:45054257..45054261,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=142 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr9:45054257..45054261,- | |||
|description=CAGE_peak_at_chr9:45054257..45054261,- | |||
|id=chr9:45054257..45054261,- | |||
|ontology_enrichment_celltype=CL:0000553!2.17e-07!6;CL:0000556!2.17e-07!6 | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,9.19e-09,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.44e-07!3;DOID:4045!2.44e-07!3 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,3.91e-24,3;DOID:4045,3.91e-24,3;DOID:0050686,1.24e-12,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,9.19e-09,9;UBERON:0002036,9.19e-09,9;UBERON:0002385,9.19e-09,9;UBERON:0000486,9.19e-09,9;UBERON:0007503,9.19e-09,9;UBERON:0001015,9.19e-09,9;UBERON:0002329,9.19e-09,9;UBERON:0003082,9.19e-09,9;UBERON:0003059,9.19e-09,9;UBERON:0007282,9.19e-09,9;UBERON:0004290,9.19e-09,9;UBERON:0009618,9.19e-09,9;UBERON:0000383,5.53e-08,10;UBERON:0007524,2.41e-07,11;UBERON:0003077,2.41e-07,11;UBERON:0007285,2.41e-07,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.473193248037357,0.685572168028694,0.42438965179803,0,0.0992909512008853,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,2.92972141515835,4.6880120671428,0,4.1176204162171,8.19654581950135,1.45653105909346,0,0,0,0,0,0,0,0,0,0.503347818173209,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.153606533256243,0,0,0,0.279182999001381,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11418387971906,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.702213187313235,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.307435147943927,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0826534557253359,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202725215290164,0,0,0.179026695667481,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr9:45054257..45054261,- | |||
}} |
Latest revision as of 04:48, 5 August 2015
Short description: | p@chr9:45054257..45054261, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr9:45054257..45054261, - |
Coexpression cluster: | MCL_coexpression_mm9:142 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 9.19e-09 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 9.19e-09 | 9 |
striated muscle tissue | 9.19e-09 | 9 |
muscle tissue | 9.19e-09 | 9 |
multilaminar epithelium | 9.19e-09 | 9 |
epithelial vesicle | 9.19e-09 | 9 |
musculature | 9.19e-09 | 9 |
somite | 9.19e-09 | 9 |
myotome | 9.19e-09 | 9 |
presomitic mesoderm | 9.19e-09 | 9 |
presumptive segmental plate | 9.19e-09 | 9 |
dermomyotome | 9.19e-09 | 9 |
trunk paraxial mesoderm | 9.19e-09 | 9 |
musculature of body | 5.53e-08 | 10 |
dense mesenchyme tissue | 2.41e-07 | 11 |
paraxial mesoderm | 2.41e-07 | 11 |
presumptive paraxial mesoderm | 2.41e-07 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 3.91e-24 | 3 |
muscle cancer | 3.91e-24 | 3 |
organ system cancer | 1.24e-12 | 6 |